Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism
In a randomized, double-blind study of three common approaches to hypothyroidism, no significant differences in symptoms were reported.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

First lab-grown mini-thyroids use patients' own tissue
(International Society for Stem Cell Research) To investigate potential alternative treatment strategies for patients with hypothyroidism, researchers have now for the first time succeeded in generating thyroid mini-organs in the lab. In a new study published in Stem Cell Reports, Robert Coppes and colleagues from the University of Groningen, The Netherlands, used healthy thyroid tissue from patients undergoing surgical removal of the thyroid to grow mini-thyroid organs in a lab which resembled thyroid glands in their structure and protein content. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 11, 2021 Category: Cancer & Oncology Source Type: news

New Trials on T3/T4 Combination for Hypothyroidism'Justified'New Trials on T3/T4 Combination for Hypothyroidism'Justified '
A joint conference concludes that new clinical trials are needed to consider evolving evidence in the ongoing debate over combination T3/T4 therapy for hypothyroidism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What Is the Best Treatment for Hypothyroidism?
Title: What Is the Best Treatment for Hypothyroidism?Category: Diseases and ConditionsCreated: 3/2/2021 12:00:00 AMLast Editorial Review: 3/2/2021 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - March 2, 2021 Category: Endocrinology Source Type: news

Janssen Announces Treatment with ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of the addition of ERLEADA® (apalutamide) to androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic castration-sensitive prostate cancer (mCSPC), regardless of extent of disease, when compared to placebo plus ADT.[1] Results will be featured in an oral presentation at the American Society of Clinical Oncology’s Genitourinary (ASCO GU) Cance...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Presents Results from Phase 3 ACIS Study in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ERLEADA ® (apalutamide) and ZYTIGA® (abiraterone acetate) Combination
RARITAN, N.J., February 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the randomized, double-blind, placebo-controlled Phase 3 ACIS study, which met the primary endpoint of radiographic progression-free survival (rPFS) with a 31 percent reduction in the risk of radiographic progression or death in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) receiving androgen deprivation therapy (ADT). Patients in the trial received either a combination of ERLEADA® and ZYTIGA® plus prednisone (combination arm) or placebo a...
Source: Johnson and Johnson - February 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

A Third Discontinuing Levothyroxine Have Normal Thyroid Levels A Third Discontinuing Levothyroxine Have Normal Thyroid Levels
Those with overt hypothyroidism are less likely to remain euthyroid than patients with subclinical disease, but many wind up restarting treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 4, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Janssen to Highlight Robust Solid Tumor Portfolio and Pipeline at 2021 ASCO GU
February 2, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it will highlight the depth of its solid tumor portfolio at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium with 12 data presentations, including three company-sponsored oral presentations from the ERLEADA® (apalutamide) clinical development program. The virtual meeting will take place February 11-13, 2021. “We are committed to the development of innovative therapies for patients with genitourinary cancers for whom there remains a high unmet need,” said C...
Source: Johnson and Johnson - February 2, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Hair loss treatment: Treating an under or overactive thyroid might boost hair growth
HAIR loss could be the result of severe and prolonged hypothyroidism or hyperthyroidism; this is confirmed by the British Thyroid Foundation. What are these conditions? (Source: Daily Express - Health)
Source: Daily Express - Health - January 27, 2021 Category: Consumer Health News Source Type: news

What Causes Lethargy?
Discussion Lethargy is a common word used to describe a person who is drowsy, sluggish, listless and apathetic. Concentration may be difficult and they may have problems doing simple tasks. Many people actual mean fatigue or lassitude or being more tired when they use the word. In medical terms, lethargy is usually used to describe patients who have some type of excessive tiredness and usually have mental status changes with decreased alertness or arousal. Patients and health care providers both usually qualify the term and give more description to better communicate what is implied when using the term. This is true of man...
Source: PediatricEducation.org - January 25, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Adding Liothyronine for Hypothyroidism Doesn't Up Breast Cancer Risk Adding Liothyronine for Hypothyroidism Doesn't Up Breast Cancer Risk
A large Swedish study shows those treated with LT3 in combination with LT4 for hypothyroidism have no greater breast cancer risk than individuals taking LT4 alone.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Consumer Health: What is hypothyroidism?
Are you over 60, feeling fatigued and slowly gaining weight? These may be subtle signs of hypothyroidism, or underactive thyroid. Your thyroid is a butterfly-shaped gland located at the base of your neck. With hypothyroidism, your thyroid gland doesn't produce enough of certain crucial hormones. As a result, hypothyroidism affects all aspects of your metabolism [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 4, 2021 Category: Databases & Libraries Source Type: news

What Effect Does Hypothyroidism Have On You?
Title: What Effect Does Hypothyroidism Have On You?Category: Diseases and ConditionsCreated: 12/15/2020 12:00:00 AMLast Editorial Review: 12/15/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - December 15, 2020 Category: Endocrinology Source Type: news

Hypothyroidism in Pregnant Woman May Raise Child's Risk of ADHD Hypothyroidism in Pregnant Woman May Raise Child's Risk of ADHD
Low levels of maternal thyroid hormone during the first three months of pregnancy may influence a fetus's brain development leaving the child at a greater risk of ADHD, a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2020 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Maternal Hypothyroidism Linked to Risk for ADHD in Offspring
Risk for ADHD increased in children of mothers with hypothyroidism diagnosed prior to, during pregnancy (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - October 21, 2020 Category: Psychiatry Tags: Endocrinology, Family Medicine, Gynecology, Internal Medicine, Neurology, Pediatrics, Psychiatry, Journal, Source Type: news

Maternal Hypothyroidism Linked to Risk for ADHD in Offspring
WEDNESDAY, Oct. 21, 2020 -- Exposure to maternal hypothyroidism during the periconceptual period is associated with an increased risk for childhood attention-deficit hyperactivity disorder (ADHD) in offspring, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 21, 2020 Category: Pharmaceuticals Source Type: news

Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism Keep Desiccated Thyroid as a Treatment Option for Hypothyroidism
Time spent in normal thyroid range over 3 years was the same whether patients took levothyroxine or desiccated thyroid; editorial says keeping the latter in the treatment tool kit is important.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 22, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

What Happens If Hypothyroidism Is Left Untreated
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - September 21, 2020 Category: General Medicine Source Type: news

Mayo Clinic Q and A: Hypothyroidism and dietary challenges
DEAR MAYO CLINIC: I was recently diagnosed with hypothyroidism and have been getting conflicting information on what I should eat and drink. I love yogurt and ice cream, for instance, but one source said a calcium-rich diet was fine, whereas another said I should limit dairy. I've also read that I should avoid soy and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 13, 2020 Category: Databases & Libraries Source Type: news

Effect of Increased Levothyroxine Dose on Depressive Mood Effect of Increased Levothyroxine Dose on Depressive Mood
Increased doses of levothyroxine may help improve depressive symptoms among older hypothyroid patients receiving hormone replacement therapy.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

What Causes Hypothyroidism?
Title: What Causes Hypothyroidism?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news

What Happens If Hypothyroidism Is Left Untreated?
Title: What Happens If Hypothyroidism Is Left Untreated?Category: Diseases and ConditionsCreated: 8/25/2020 12:00:00 AMLast Editorial Review: 8/25/2020 12:00:00 AM (Source: MedicineNet Thyroid General)
Source: MedicineNet Thyroid General - August 25, 2020 Category: Endocrinology Source Type: news

Have I Been Doing This Exam Wrong All This Time? Have I Been Doing This Exam Wrong All This Time?
The Curbsiders share their favorite tips from a jam-packed podcast on hypothyroidism.The Curbsiders (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - August 24, 2020 Category: Universities & Medical Training Tags: Diabetes & Endocrinology Commentary Source Type: news

FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review.   The review was also conducted under Project Orbis, an initiative of the FDA On...
Source: Roche Investor Update - July 31, 2020 Category: Pharmaceuticals Source Type: news

FDA approves Roche ’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanoma
Basel, 31 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq ® (atezolizumab) plus Cotellic® (cobimetinib) and Zelboraf® (vemurafenib) for the treatment of BRAF V600 mutation-positive advanced melanoma patients.  The safety profile observed in the Tecentriq combination was consistent with the known safety profiles of the individual medicines. The supplemental Biologics License Application (sBLA) for Tecentriq was granted under priority review.   The review was also conducted under Project Orbis, an initiative of the FDA On...
Source: Roche Media News - July 31, 2020 Category: Pharmaceuticals Source Type: news

Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI Levothyroxine: No LV Benefit in Subclinical Hypothyroidism With MI
Screening for and subsequent treatment of subclinical hypothyroidism in patients with acute MI to preserve left ventricular function is not justified, the ThyrAMI-2 trialists conclude.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 24, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Bestselling Author Releases Free Deep Dive Educational Webinar and...
Nationally-known patient advocate and bestselling author Mary Shomon has launched a free educational program on levothyroxine, the most commonly prescribed medication to treat hypothyroidism, and one...(PRWeb July 21, 2020)Read the full story at https://www.prweb.com/releases/bestselling_author_releases_free_deep_dive_educational_webinar_and_book_on_levothyroxine_the_most_prescribed_medication_for_hypothyroidism/prweb17267808.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 21, 2020 Category: Pharmaceuticals Source Type: news

Contribute to survey on treatment of hypothyroidism in Europe
You are invited to contribute to a series of national surveys of physicians on the management of hypothyroidism in Europe (THESIS; Treatment of Hypothyroidism in Europe by Specialists: an International Survey).The survey aims to gather information from physicians on a number of clinical practice topics relating to hypothyroidism. Whereas such data have been published from the US, there are few reflecting European practices. Twenty three European countries are already taking part.To help with the UK survey, which involves completing an online questionnaire, email Dr Carla Moran atcm682@me...
Source: Society for Endocrinology - July 16, 2020 Category: Endocrinology Source Type: news

Newborn Iodine Status Not Tied to Congenital Hypothyroidism
THURSDAY, July 9, 2020 -- Blood iodine concentrations in newborns do not vary for infants with or without congenital hypothyroidism (CH), although they are higher in cases versus controls in the neonatal intensive care unit (NICU), according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2020 Category: Pharmaceuticals Source Type: news

Subclinical Hypothyroidism Appears Common in Women With Miscarriage Subclinical Hypothyroidism Appears Common in Women With Miscarriage
Among women with a history of miscarriage or subfertility, the prevalence of subclinical hypothyroidism is about 20% when using a TSH cutoff of 2.5 mIU/L.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 2, 2020 Category: Endocrinology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Increased Hypothyroidism Risk Seen in Young Men With HS Increased Hypothyroidism Risk Seen in Young Men With HS
Hidradenitis suppurativa (HS) increases the risk for hypothyroidism in young men, but not in young women or any older adults, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2020 Category: Consumer Health News Tags: Dermatology News Source Type: news

Mild Thyroid Dysfunction Common in Women With Subfertility
WEDNESDAY, June 17, 2020 -- Among women with a history of miscarriage or subfertility trying for a pregnancy, mild subclinical hypothyroidism (SCH) is common, according to a study published online June 17 in the Journal of Clinical Endocrinology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 17, 2020 Category: Pharmaceuticals Source Type: news

L-T4 Before Breakfast vs at Bedtime in Hypothyroidism L-T4 Before Breakfast vs at Bedtime in Hypothyroidism
When is the best time of day to administer L-thyroxine in patients with hypothyroidism? A new meta-analysis compares the effects of different timings.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 16, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

The Role of Serum Procalcitonin in Predicting Bacterial Sepsis in Patients with Hypothyroidism
Conclusion(s): Despite the thyroidal origin of PCT, hypothyroidism did not affect the diagnostic performance of serum PCT levels in predicting bacterial sepsis or septic shock. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 4, 2020 Category: Consumer Health News Source Type: news

Thyroid Dysfunction in Pregnancy Overdiagnosed, Overtreated
MONDAY, June 1, 2020 -- Current practice patterns relating to testing and management of thyroid-stimulating hormone (TSH) during pregnancy are associated with overdiagnosis and overtreatment of hypothyroidism, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2020 Category: Pharmaceuticals Source Type: news

U.S. FDA Approves New Pediatric Formulation of SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received acceler...
Source: Johnson and Johnson - May 27, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

' Superpotent' Lots of NP Thyroid for Hypothyroidism Recalled in US'Superpotent' Lots of NP Thyroid for Hypothyroidism Recalled in US
Thirteen lots of the combination T4/T3 product have been voluntarily recalled as they may contain 115% of the labeled amount of T3. Patients should not stop taking the pills without medical advice.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 27, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news

How Long Does Neonatal Galactorrhea Last?
Discussion Galactorrhea is a milky discharge from the breast in a non-lactating female. Neonatal galactorrhea is sometimes called “Witch’s Milk” based on ideas from the 17th century or earlier that witches would steal the milk for use in their magic. Infant breasts were often compressed to express the fluid and prevent its collection. During the 19th century, reports of breast inflammation and even abscess were reported because of this practice and it was strongly discouraged, and continues to not be recommended today. Enlargement of neonatal breasts and galactorrhea, both for males and females, is fel...
Source: PediatricEducation.org - May 25, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Brian Added 28 Years to His Life … with Telomere Anti-Aging
In a brand-new study, Ivy League researchers report that they’ve isolated a compound in human stem cells called PAPD5 that can treat “telomere diseases” and reverse cellular aging.1 Of course, like many in mainstream medicine, the first thought is how to turn this natural enzyme into a patented drug that targets stem cells to restore telomeres. It’s yet another example of Big Pharma’s attempt to profit from your God-given genes. But you don’t need a “telomere drug” to reverse cellular aging… In a moment, I’ll show you two natural ways you can easily protect your ...
Source: Al Sears, MD Natural Remedies - May 21, 2020 Category: Complementary Medicine Authors: Dr.A.Sears Tags: Anti-Aging Health Source Type: news

Hypothyroidism and Your Hands
Can You Tell If You Have Hypothyroidism by Looking at Your Hands? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 15, 2020 Category: General Medicine Source Type: news

ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
RARITAN, NJ, May 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA® (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.[i] Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Program (Abstract #5516) beginning May 29th. ERLEADA® ...
Source: Johnson and Johnson - May 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

L-Thyroxine Does Not Improve Subclinical Hypothyroidism in ≥65s
TUESDAY, May 5, 2020 -- L-thyroxine does not improve hypothyroid symptoms or tiredness among older adults with subclinical hypothyroidism (SCH) and high symptom burden, according to a study published online May 5 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 5, 2020 Category: Pharmaceuticals Source Type: news

Synthroid May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Common Treatment, Synthroid, May Not Help Seniors With Subclinical Thyroid
MONDAY, May 4, 2020 -- The medication Synthroid (levothyroxine) is often used to treat a condition called subclinical hypothyroidism, but a new study suggests the treatment might be a waste of time. For the study, researchers followed 638 people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 4, 2020 Category: General Medicine Source Type: news

Fragile X in the Family
Discussion Fragile X syndrome (FXS) was first clinically described in 1943 by Martin-Bell and in 1969 Lubs found a fragility at the terminal end of the X chromosome. In 1991, three different research groups independently cloned the mutation for the FMR1 gene (Fragile X mental retardation type 1) which has a CGG triplet expansion. The FMR1 gene codes for the FMR protein which is a major regulator of synaptic plasticity and is expressed in the brain and spermatogonia mainly but many other tissues during fetal and early neonatal development. The number of triplets and methylation correlates with clinical expression (increased...
Source: PediatricEducation.org - April 27, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Patients Say Desiccated Thyroid Better Than Standard Therapy Patients Say Desiccated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 14, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Patients Say Dessicated Thyroid Better Than Standard Therapy Patients Say Dessicated Thyroid Better Than Standard Therapy
Patients with hypothyroidism taking desiccated thyroid extract such as Armour perceive it works better than synthetic levothyroxine alone, despite lack of data and known risks.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 13, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Does Thyroid Hormone Therapy in Older Age Increase Risk of Death? Does Thyroid Hormone Therapy in Older Age Increase Risk of Death?
Whether or not the mortality finding is real, one expert says, in any case, levothyroxine doesn't make older patients with subclinical hypothyroidism feel any better, so is unwarranted.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 6, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Hypothyroid treatment may increase mortality risk
According to a study published in the the Journal of the Endocrine Society, adults over the age of 65 receiving thyroid replacement therapy may have an increased risk of death by up to 60%.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 1, 2020 Category: Endocrinology Source Type: news

Being Chained to Your Desk Might Harm Your Thyroid
TUESDAY, March 31, 2020 -- Could long hours at the office put you at risk for hypothyroidism? New research suggests it's possible: Hypothyroidism (an underactive thyroid) was more than twice as common in adults who worked 53 to 83 hours a week as in... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 31, 2020 Category: General Medicine Source Type: news